Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
XFOR
XFOR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XFOR News
Sanofi Acquires Dynavax for $15.50 per Share, Totaling $2.2 Billion
Dec 24 2025
Benzinga
Examining X4 Pharmaceuticals' Story Following Leadership Transitions and Recent Funding
Nov 24 2025
Yahoo Finance
Insider Buying Update for Tuesday, October 28: CRMD and XFOR
Oct 28 2025
NASDAQ.COM
Healthcare Rally: Pulmonx, UHS, and X4 Experience After-Hours Gains Following Strategic Announcements
Oct 28 2025
NASDAQ.COM
X4 Pharmaceuticals Sees 5% Decline After Pricing $135M Equity Offering
Oct 24 2025
SeekingAlpha
X4 Pharmaceuticals (XFOR) Receives Strong Buy Upgrade: Implications for the Stock
Oct 22 2025
NASDAQ.COM
Altimmune Names Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Lead Clinical Development of Pemvidutide
Sep 28 2025
Globenewswire
X4 Pharmaceuticals Implements Restructuring Following CMO Resignation; Aims for $13 Million Savings with 50% Workforce Reduction
Sep 17 2025
NASDAQ.COM
Sitryx Names Adam Mostafa as CFO
Sep 08 2025
Newsfilter
3 Penny Stocks to Watch Now, 8/14/25
Aug 14 2025
TipRanks
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
Aug 13 2025
Newsfilter
X4 Pharma Secures $60 Mln PIPE Financing; CEO, CFO Resign; Replacements Named
Aug 12 2025
NASDAQ.COM
X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership
Aug 12 2025
Newsfilter
X4 Pharmaceuticals secures $60M PIPE financing
Aug 12 2025
SeekingAlpha
X4 Pharmaceuticals: Q2 Earnings Snapshot
Aug 08 2025
Yahoo Finance
X4 Pharma Unveils Encouraging Phase 2 Data On Mavorixafor At EHA Congress
Jun 16 2025
NASDAQ.COM
Show More News
